SCALE Diabetes

Definition

The phase 3 trial of liraglutide 3.0 mg (Saxenda) in adults with obesity AND type 2 diabetes. Davies and colleagues (JAMA 2015) reported -6.0% body weight at 56 weeks on liraglutide versus -2.0% on placebo — establishing the indication-expansion to the T2D + obesity population that Saxenda still serves.

SCALE Diabetes trial deep-dive →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• STEP 2
• SUMMIT
• SCALE Maintenance

Looking for more depth?

• SCALE Diabetes trial deep-dive
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers